Provided by Tiger Trade Technology Pte. Ltd.

Maravai LifeSciences Holdings, Inc.

3.11
+0.03000.97%
Post-market: 3.110.00000.00%17:19 EDT
Volume:1.29M
Turnover:4.04M
Market Cap:799.48M
PE:-3.43
High:3.20
Open:3.12
Low:3.04
Close:3.08
52wk High:4.11
52wk Low:1.67
Shares:257.07M
Float Shares:202.67M
Volume Ratio:0.51
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9059
EPS(LYR):-0.9059
ROE:-48.59%
ROA:-8.83%
PB:3.76
PE(LYR):-3.43

Loading ...

May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 22, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 01, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2022

Major Issues Report

8-K - Current report
Oct 19, 2022

Major Issues Report

8-K - Current report
Oct 03, 2022

Major Issues Report

8-K - Current report
Sep 06, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 06, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Aug 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2022

Major Issues Report

8-K - Current report
Jul 12, 2022

Correspondence

CORRESP [Cover] - Correspondence